A Phase I/II, open-label, two part study of GSK3359609 in combination with tremelimumab in participants with selected, advanced solid tumorsAaron Hansen,Raghad Abdul-Karim,Naiyer Rizvi,Danny Rischen,John Hilton,Zujun Li,Patrick Ott,Natalie Karpinich-Fedoriw,Sapna Yadavilli,Xiaowei Wang,Laurel Adams, Melody Wyres,Charles Ferte,Marc Ballas,Axel Hoos, Daniel ZandbergCANCER RESEARCH(2019)引用 1|浏览37暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要